select trial semaglutide cardiovascular outcomes non-diabetic 2023 Long-term weight loss effects of in obesity without diabetes in the Insights into semaglutide cardiovascular research:

It is important to understand the difference between: how long tirzepatide stays in the bloodstream how long its effects continue Even after medication levels decline, some people continue to experience: reduced appetite improved blood sugar stability slower digestion ongoing weight management progress These effects gradually decrease over time after discontinuation

A 2003 law bars Medicare's Part D drug benefit from covering any medication used for weight loss

doi: 10.1186/s13068-022-02181-3 232 ZhugeALiSHanSYuanYShenJWuWet al

One medical perspective highlights that reported hair loss may be indirectly related to stressors such as rapid weight reduction, nutritional gaps, or a temporary condition known as telogen effluvium rather than a direct pharmacologic effect